Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases.
Ratings
0 / 5
0 ratings in the last 12 months
5
4
3
2
1
CEO
Mr. Peter M. Hecht, PhD$8.2M
Market Cap • 25/04/20242018
(há 6 anos)
2019
(5 years ago)
NASDAQ
Listagem
Cambridge
Sede • Massachusetts16
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
CYCNSó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.